17-1716626-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_001163673.2(WDR81):c.51C>T(p.Ser17Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00322 in 1,551,704 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0033 ( 6 hom. )
Consequence
WDR81
NM_001163673.2 synonymous
NM_001163673.2 synonymous
Scores
2
5
Clinical Significance
Conservation
PhyloP100: 0.554
Genes affected
WDR81 (HGNC:26600): (WD repeat domain 81) This gene encodes a multi-domain transmembrane protein which is predominantly expressed in the brain and is thought to play a role in endolysosomal trafficking. Mutations in this gene are associated with an autosomal recessive form of a syndrome exhibiting cerebellar ataxia, cognitive disability, and disequilibrium (CAMRQ2). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.00956881).
BP6
Variant 17-1716626-C-T is Benign according to our data. Variant chr17-1716626-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2578776.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr17-1716626-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.554 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00209 (319/152396) while in subpopulation NFE AF = 0.00357 (243/68034). AF 95% confidence interval is 0.0032. There are 0 homozygotes in GnomAd4. There are 139 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR81 | ENST00000446363 | c.-397C>T | 5_prime_UTR_variant | Exon 1 of 9 | 1 | ENSP00000401560.1 | ||||
WDR81 | ENST00000468539.5 | c.55C>T | p.Arg19Cys | missense_variant | Exon 1 of 4 | 4 | ENSP00000460742.1 | |||
WDR81 | ENST00000437219.6 | c.51C>T | p.Ser17Ser | synonymous_variant | Exon 1 of 10 | 2 | ENSP00000391074.2 |
Frequencies
GnomAD3 genomes AF: 0.00209 AC: 319AN: 152278Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
319
AN:
152278
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00187 AC: 293AN: 156536 AF XY: 0.00183 show subpopulations
GnomAD2 exomes
AF:
AC:
293
AN:
156536
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00334 AC: 4676AN: 1399308Hom.: 6 Cov.: 30 AF XY: 0.00317 AC XY: 2190AN XY: 690146 show subpopulations
GnomAD4 exome
AF:
AC:
4676
AN:
1399308
Hom.:
Cov.:
30
AF XY:
AC XY:
2190
AN XY:
690146
Gnomad4 AFR exome
AF:
AC:
13
AN:
31598
Gnomad4 AMR exome
AF:
AC:
40
AN:
35700
Gnomad4 ASJ exome
AF:
AC:
28
AN:
25182
Gnomad4 EAS exome
AF:
AC:
0
AN:
35738
Gnomad4 SAS exome
AF:
AC:
100
AN:
79230
Gnomad4 FIN exome
AF:
AC:
131
AN:
49206
Gnomad4 NFE exome
AF:
AC:
4157
AN:
1078958
Gnomad4 Remaining exome
AF:
AC:
203
AN:
57998
Heterozygous variant carriers
0
251
502
752
1003
1254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00209 AC: 319AN: 152396Hom.: 0 Cov.: 33 AF XY: 0.00187 AC XY: 139AN XY: 74528 show subpopulations
GnomAD4 genome
AF:
AC:
319
AN:
152396
Hom.:
Cov.:
33
AF XY:
AC XY:
139
AN XY:
74528
Gnomad4 AFR
AF:
AC:
0.000456731
AN:
0.000456731
Gnomad4 AMR
AF:
AC:
0.00124069
AN:
0.00124069
Gnomad4 ASJ
AF:
AC:
0.00172811
AN:
0.00172811
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00103434
AN:
0.00103434
Gnomad4 FIN
AF:
AC:
0.00216409
AN:
0.00216409
Gnomad4 NFE
AF:
AC:
0.00357174
AN:
0.00357174
Gnomad4 OTH
AF:
AC:
0.00141777
AN:
0.00141777
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
16
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
11
ExAC
AF:
AC:
29
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
WDR81: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
MetaRNN
Benign
T
MVP
GERP RS
Mutation Taster
=299/1
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at